Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBLGNASDAQ:HSCSNASDAQ:NAOVNASDAQ:SRGA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBLGBone Biologics$0.70+4.0%$0.78$0.57▼$4.25$2.29M0.531.39 million shs13,740 shsHSCSHeart Test Laboratories$3.48-0.9%$3.13$2.36▼$13.50$3.76M2.71127,029 shs3,110 shsNAOVNanoVibronix$3.88+35.7%$4.55$1.92▼$16.25$2.95M1.84761,430 shs22.18 million shsSRGASurgalign$0.76$0.17▼$6.77$1.69M1.551.44 million shs8.72 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBLGBone Biologics-3.60%-1.38%-15.89%-39.92%-56.91%HSCSHeart Test Laboratories+0.03%+5.09%+24.47%+6.36%-62.01%NAOVNanoVibronix-22.91%-52.81%-16.13%-55.93%-64.98%SRGASurgalign0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBLGBone Biologics0.8981 of 5 stars0.02.00.00.03.80.01.3HSCSHeart Test Laboratories2.2559 of 5 stars3.53.00.00.01.90.01.3NAOVNanoVibronix0.2551 of 5 stars0.02.00.00.03.00.00.0SRGASurgalignN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBLGBone Biologics 0.00N/AN/AN/AHSCSHeart Test Laboratories 3.00Buy$13.00273.56% UpsideNAOVNanoVibronix 0.00N/AN/AN/ASRGASurgalign 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SRGA, HSCS, NAOV, and BBLG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/18/2025HSCSHeart Test LaboratoriesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $14.00(Data available from 5/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBLGBone BiologicsN/AN/AN/AN/A$7.42 per shareN/AHSCSHeart Test Laboratories$14.70K255.91N/AN/A$11.16 per share0.31NAOVNanoVibronix$2.56M1.15N/AN/A$1.95 per share1.99SRGASurgalign$81.98M0.00N/AN/A($3.81) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBLGBone Biologics-$8.95MN/A0.00N/AN/AN/A-124.71%-111.64%5/13/2025 (Estimated)HSCSHeart Test Laboratories-$6.61M-$7.48N/AN/AN/AN/A-117.76%-84.09%N/ANAOVNanoVibronix-$3.71M-$13.53N/A∞N/A-93.80%-101.17%-53.03%5/21/2025 (Estimated)SRGASurgalign-$54.60M-$8.12N/AN/AN/A-64.63%-983.11%-74.49%N/ALatest SRGA, HSCS, NAOV, and BBLG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/13/2025Q3 2025HSCSHeart Test Laboratories-$2.53-$2.5722-$0.0422-$2.57N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBLGBone BiologicsN/AN/AN/AN/AN/AHSCSHeart Test LaboratoriesN/AN/AN/AN/AN/ANAOVNanoVibronixN/AN/AN/AN/AN/ASRGASurgalignN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBLGBone BiologicsN/A14.8914.89HSCSHeart Test Laboratories0.011.721.52NAOVNanoVibronixN/A1.740.84SRGASurgalignN/A2.672.00Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBLGBone Biologics34.30%HSCSHeart Test Laboratories17.24%NAOVNanoVibronix16.39%SRGASurgalign26.31%Insider OwnershipCompanyInsider OwnershipBBLGBone Biologics7.50%HSCSHeart Test Laboratories1.80%NAOVNanoVibronix7.00%SRGASurgalign3.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBLGBone Biologics23.27 million2.31 millionNot OptionableHSCSHeart Test Laboratories101.08 million962,000Not OptionableNAOVNanoVibronix20759,0003.49 millionNot OptionableSRGASurgalign2179.24 million8.96 millionOptionableSRGA, HSCS, NAOV, and BBLG HeadlinesRecent News About These CompaniesSurgalign Holdings Inc.November 4, 2023 | thestreet.comSurgalign Holdings Inc (SRGAQ)August 15, 2023 | investing.comRT20.BE - SURGALIGN HLDGS NEW -,001July 10, 2023 | finance.yahoo.comWhy Is Surgalign Holdings (SRGA) Stock Up 10% Today?June 27, 2023 | investorplace.comShort Volatility Alert: Surgalign HoldingsJune 26, 2023 | benzinga.comWhy Is Surgalign Holdings (SRGA) Stock Down 23% Today?June 26, 2023 | investorplace.comSurgalign Holdings, Inc.: Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 FilingJune 23, 2023 | finanznachrichten.deSurgalign receives Nasdaq delisting notice following bankruptcy filingJune 23, 2023 | massdevice.comSurgalign Receives NASDAQ Delisting Notice Following its Chapter 11 FilingJune 23, 2023 | finance.yahoo.comSurgalign files Chapter 11 to sell global hardware, biologics businessJune 20, 2023 | massdevice.comSurgalign Files For Bankruptcy, Agrees To Sell Global Hardware & Biologics BusinessJune 20, 2023 | benzinga.comSurgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale Process Under Chapter 11 of the U.S. Bankruptcy CodeJune 20, 2023 | finance.yahoo.comWhy Is Surgalign (SRGA) Stock Down 55% Today?June 20, 2023 | investorplace.comSurgalign plummets 42% on bankruptcy filingJune 20, 2023 | msn.comSurgalign Plummets on Chapter 11 FilingJune 20, 2023 | msn.comMedtech firm Surgalign files for Chapter 11 bankruptcyJune 20, 2023 | dunyanews.tvSurgalign (SRGA) Upgraded to Buy: What Does It Mean for the Stock?June 5, 2023 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Athira Pharma (ATHA) and Surgalign Holdings (SRGA)May 23, 2023 | markets.businessinsider.comSurgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education ResourcesMay 23, 2023 | finance.yahoo.comSurgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations - Yahoo FinanceMay 13, 2023 | news.google.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSRGA, HSCS, NAOV, and BBLG Company DescriptionsBone Biologics NASDAQ:BBLG$0.70 +0.03 (+4.03%) Closing price 04:00 PM EasternExtended Trading$0.69 -0.01 (-2.00%) As of 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.Heart Test Laboratories NASDAQ:HSCS$3.48 -0.03 (-0.85%) Closing price 03:59 PM EasternExtended Trading$3.50 +0.02 (+0.72%) As of 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.NanoVibronix NASDAQ:NAOV$3.88 +1.02 (+35.66%) Closing price 04:00 PM EasternExtended Trading$3.82 -0.06 (-1.55%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.Surgalign NASDAQ:SRGASurgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spinal hardware implants and biomaterial products worldwide. It offers products for thoracolumbar procedures, including Streamline TL spinal fixation system, a system for degenerative and complex spine procedures; and Streamline MIS spinal fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops augmented reality and artificial intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. On June 19, 2023, Surgalign Holdings, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Crushes Earnings, What’s Next for MSFT Stock? McDonald’s Insiders Sell Shares! Investors Should Do the Opposite Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay Away Broadcom: Buy, Hold, Sell? AI & Acquistions Paint Strong Picture Hershey Hits the Sweet Spot for Defensive Investors A Bull Case for Adobe Stock Remains Today AMD Stock Signals Strong Buy Ahead of Earnings BigBear.ai: A Short-Squeeze Is Possible, a Sharp Drop Is Likely Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
